Haleon Plc - ADR | Large-cap | Healthcare
$10.35
-0.19%
| Haleon Plc - ADR Stock Comparison:
Haleon Plc - ADR vs ZoetisHaleon Plc - ADR vs United TherapeuticsHaleon Plc - ADR vs Intra-CellularHaleon Plc - ADR vs NeurocrineHaleon Plc - ADR vs ViatrisHaleon Plc - ADR vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 11.2B
Gross Profit 6.8B 60.75%
Operating Income 2.2B 19.64%
Net Income 1.5B 13.13%
EPS (Diluted) $0.31

Balance Sheet Metrics

Total Assets 34.3B
Total Liabilities 18.1B
Shareholders Equity 16.2B
Debt to Equity 1.12

Cash Flow Metrics

Operating Cash Flow 1.9B
Free Cash Flow 2.0B

Revenue & Profitability Trend

Haleon Plc - ADR Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 11.2B 11.3B 10.9B 9.5B 9.9B
Cost of Goods Sold 4.4B 4.6B 4.3B 3.6B 4.0B
Gross Profit 6.8B 6.7B 6.6B 6.0B 5.9B
Research & Development 298.0M 311.0M 300.0M 257.0M 304.0M
Selling, General & Administrative 4.5B 4.4B 4.5B 4.1B 4.2B
Other Operating Expenses -132.0M 27.0M -31.0M -31.0M -212.0M
Total Operating Expenses 4.6B 4.8B 4.8B 4.3B 4.3B
Operating Income 2.2B 2.0B 1.8B 1.6B 1.6B
Pre-tax Income 1.9B 1.6B 1.6B 1.6B 1.6B
Income Tax 435.0M 517.0M 499.0M 197.0M 410.0M
Net Income 1.5B 1.1B 1.1B 1.4B 1.2B
EPS (Diluted) $0.31 $0.23 $0.23 $0.30 $0.25

Income Statement Trend

Haleon Plc - ADR Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 5.7B 4.8B 4.1B 5.3B 5.0B
Non-Current Assets 28.6B 29.2B 30.8B 29.2B 29.1B
Total Assets 34.3B 34.1B 34.8B 34.5B 34.1B
Liabilities
Current Liabilities 5.8B 4.6B 4.4B 4.2B 4.0B
Non-Current Liabilities 12.3B 12.7B 14.0B 3.7B 3.9B
Total Liabilities 18.1B 17.3B 18.4B 8.0B 7.9B
Equity
Total Shareholders Equity 16.2B 16.7B 16.5B 26.5B 26.2B

Balance Sheet Composition

Haleon Plc - ADR Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 1.5B 1.1B 1.1B 1.4B 1.2B
Operating Cash Flow 1.9B 1.3B 1.1B 1.5B 1.8B
Investing Activities
Capital Expenditures -250.0M -234.0M -304.0M -216.0M -216.0M
Investing Cash Flow 196.0M -305.0M 396.0M -116.0M 183.0M
Financing Activities
Dividends Paid -570.0M -388.0M -2.7B -1.1B -2.4B
Financing Cash Flow -1.0B -1.1B 7.2B -1.1B -2.4B
Free Cash Flow 2.0B 1.8B 1.7B 1.1B 1.1B

Cash Flow Trend

Haleon Plc - ADR Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 25.01
Forward P/E 25.01
Price to Book 5.88
Price to Sales 4.20
PEG Ratio 25.01

Profitability Ratios

Profit Margin 12.84%
Operating Margin 22.87%
Return on Equity 8.95%
Return on Assets 4.55%

Financial Health

Current Ratio 0.98
Debt to Equity 63.41
Beta 0.24

Per Share Data

EPS (TTM) $0.42
Book Value per Share $1.79
Revenue per Share $2.46

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
hln 47.2B 25.01 5.88 8.95% 12.84% 63.41
Zoetis 70.3B 28.34 15.12 52.09% 27.12% 145.63
United Therapeutics 12.9B 11.41 1.90 19.94% 40.44% 2.94
Intra-Cellular 14.0B -183.15 12.20 -8.58% -10.97% 1.48
Neurocrine 12.5B 42.90 4.94 12.43% 12.68% 19.45
Viatris 10.4B 235.80 0.67 -21.25% -26.45% 92.38

Financial data is updated regularly. All figures are in the company's reporting currency.